**Author details**

Natalia Jorgelina Prado1,2, Margarita Segovia-Roldan2 , Emiliano Raúl Diez1,2\* and Esther Pueyo1,2

1 Medical Faculty, CONICET, IMBECU, National University of Cuyo, Mendoza, Argentina

2 I3A, Universidad de Zaragoza, IIS Aragón and CIBER-BBN, Zaragoza, Spain

\*Address all correspondence to: diez.emiliano@fcm.uncu.edu.ar

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**63**

*Melatonin for a Healthy Heart Rhythm*

**References**

2015;**36**:2793-2867

[2] Black N, D'Souza A, Wang Y, Piggins H, Dobrzynski H, Morris G, et al. Circadian rhythm of cardiac electrophysiology, arrhythmogenesis, and the underlying mechanisms. Heart

[3] Baltatu OC, Senar S, Campos LA, Cipolla-Neto J. Cardioprotective melatonin: Translating from proofof-concept studies to therapeutic use. International Journal of Molecular

Rhythm. 2019;**16**:298-307

Sciences. 2019;**20**:4342

Research. 2018;**64**:e12471

2019;**9**:327-335

[4] Zhou H, Ma Q, Zhu P, Ren J, Reiter RJ, Chen Y. Protective role of melatonin in cardiac ischemiareperfusion injury: From pathogenesis to targeted therapy. Journal of Pineal

[5] Pliss MG, Kuzmenko NV, Rubanova NS, Tsyrlin VA. Dose-dependent mechanisms of melatonin on the functioning of the cardiovascular system and on the behavior of normotensive rats of different ages. Advances in Gerontology.

[6] Jiki Z, Lecour S, Nduhirabandi F. Cardiovascular benefits of dietary melatonin: A myth or a reality? Frontiers in Physiology. 2018;**9**:528

[7] Favero G, Franceschetti L, Buffoli B, Moghadasian MH, Reiter RJ, Rodella LF, et al. Melatonin: Protection against age-related cardiac pathology. Ageing Research Reviews. 2017;**35**:336-349

[8] Egan Benova T, Viczenczova C, Szeiffova Bacova B, Knezl V, Dosenko V,

*DOI: http://dx.doi.org/10.5772/intechopen.91447*

[1] Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. European Heart Journal.

Rauchova H, et al. Obesity-associated alterations in cardiac connexin-43 and PKC signaling are attenuated by melatonin and omega-3 fatty acids in female rats. Molecular and Cellular Biochemistry. 2019;**454**:191-202

[9] Singhanat K, Apaijai N, Chattipakorn SC, Chattipakorn N. Roles of melatonin and its receptors in cardiac ischemia– reperfusion injury. Cellular and Molecular

[10] Pandi-Perumal SR, BaHammam AS, Ojike NI, Akinseye OA, Kendzerska T, Buttoo K, et al. Melatonin and human cardiovascular disease. Journal of Cardiovascular Pharmacology and Therapeutics. 2017;**22**:122-132

[11] Prado NJ, Ferder L, Manucha W, Diez ER. Anti-inflammatory effects of melatonin in obesity and hypertension.

[12] Crnko S, Du Pré BC, Sluijter JPG, Van Laake LW. Circadian rhythms and the molecular clock in cardiovascular biology and disease. Nature Reviews.

Current Hypertension Reports.

Cardiology. 2019;**16**:437-447

Research. 2020;**126**:258-279

[13] Rana S, Prabhu SD, Young ME. Chronobiological influence over cardiovascular function. Circulation

[14] Martino TA, Young ME. Influence of the cardiomyocyte circadian clock on cardiac physiology and pathophysiology. Journal of Biological Rhythms. 2015;**30**:

[15] Zhou H, Yue Y, Wang J, Ma Q, Chen Y. Melatonin therapy for diabetic

[16] Yang Y, Sun Y, Yi W, Li Y, Fan C, Xin Z, et al. A review of melatonin as a

cardiomyopathy: A mechanism involving Syk-mitochondrial complex I-SERCA pathway. Cellular Signalling.

2018;**20**:45

183-205

2018;**47**:88-100

Life Sciences. 2018;**75**:4125-4149

*Melatonin for a Healthy Heart Rhythm DOI: http://dx.doi.org/10.5772/intechopen.91447*
